Other
Skin Testing
Skin Testing is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
25%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
not_yet_recruiting125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_4
The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron
NCT07103720
not_yet_recruiting
Persistence of Sensitization to Contrast Media
NCT07409051
completednot_applicable
Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation
NCT04046731
completednot_applicable
Basophile Activation Testing (BAT) in Hazelnut Allergy (Hazelnut BAT Study)
NCT03079206
Clinical Trials (4)
Showing 4 of 4 trials
NCT07103720Phase 4
The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron
NCT07409051
Persistence of Sensitization to Contrast Media
NCT04046731Not Applicable
Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation
NCT03079206Not Applicable
Basophile Activation Testing (BAT) in Hazelnut Allergy (Hazelnut BAT Study)
All 4 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 4